| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.25B | +22.9% |
| Cost of Revenue | $1.57B | +16.3% |
| Gross Profit | $5.67B | +24.9% |
| R&D Expense | $1.77B | +26.6% |
| SG&A Expense | $735.0M | +23.1% |
| Operating Income | $355.0M | +38.1% |
| Interest Expense | $27.0M | -3.6% |
| Pre-tax Income | $399.0M | +60.2% |
| Income Tax | $74.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.47B | -14.9% |
| Accounts Receivable | $1.73B | +24.1% |
| Current Assets | $6.65B | +27.5% |
| Total Assets | $13.30B | +23.2% |
| Current Liabilities | $6.00B | +21.3% |
| Total Liabilities | $8.27B | +16.4% |
| Stockholders' Equity | $5.03B | +36.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.72B | +24.3% |
| Capital Expenditures | $550.0M | +40.3% |
| Investing Cash Flow | -$2.58B | -60.7% |
| Financing Cash Flow | -$344.0M | +32.0% |
| Free Cash Flow | $2.17B | +20.8% |
| +289.5% |
| Net Income | $325.0M | +41.2% |
| EPS (Basic) | $1.61 | +38.8% |
| EPS (Diluted) | $1.60 | +41.6% |